Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I have major problems with this PR. First, "Goes the Distance" means nothing to me. Second, if 12000 sampled the bar at the expo, does that mean the runners did not get any bars? Third, that one person thought it was the best tasting bar he/she had ever tasted - - well there is always one person out of 12000 who would think snails with chocolate chip ice cream was the best thing he had ever tasted. It means nothing. Same with mentioning the retailer Foot Zone - - who they?
Biggest issue is that the overall plan of marketing was not mentioned, which is to open an area for retail sales by making a splash at a big event like the local marathon. We are not talking Podunk here, Seattle is major. San Diego was major. Chicago coming up is major. It is an excellent marketing strategy for a lean budget - - why not say it??
Maybe biggest issue is that one in ten ordered the bars. Not knowing what the industry standard is for these sample things, I have no idea whether this is good or not. I think from my own experience sampling stuff at expos that a one in ten ordering is terrific - - but how in the hell is the stock market going to know that?
FORZE GPS Goes the Distance at Seattle Rock 'n' Roll Marathon
“Official Bar” of Rock ‘n’ Roll Marathon Series Draws Big Crowds and Acquires New Fans
MATAWAN, N.J.--(BUSINESS WIRE)--PacificHealth Laboratories, Inc. (OTCBB: PHLI - News), a leading sports nutrition company, today announced that more than 12,000 consumers sampled FORZE GPS™ nutrition bars at the Seattle Rock ‘n’ Roll Marathon, Half Marathon and Expo, held June 25-27, 2009. A total of 25,000 runners participated in the sold out event which marks the second of 19 races featuring FORZE GPS as the “Official Bar” of the Rock ‘n’ Roll Marathon series.
Consumers overwhelmingly loved the taste of FORZE GPS bars according to Jason Ash, CEO of PacificHealth Labs, Inc. “When people realize that FORZE GPS is not only delicious, but that it is also an extremely effective weight management tool they are amazed - and immediately become fervent brand advocates," said Ash. “The continued exposure we are receiving from the Rock ‘n’ Roll marathon series has resulted in more and more people requesting product from their local retailers at and around the events.”
The next event in the series, the Rock ‘n’ Roll Half Marathon in Chicago on August 2, is expected to continue to build both distribution and consumer momentum.
More than 12,000 people sampled FORZE GPS bars at the Seattle health and fitness expo held two days prior to the event. According to one attendee, “This is the best bar I’ve ever tasted!” In fact, one in ten consumers who sampled product purchased FORZE GPS bars from on site retail partner Foot Zone.
Currently, over 275 sports specialty retailers carry FORZE GPS products, and the Company recently announced an ambitious sampling program to reach more than one million consumers with FORZE GPS in 2009 following the brand’s launch on March 23rd.
Athletes know that the leaner a body becomes, the greater its potential for speed and performance. FORZE GPS is the first scientifically proven appetite management tool created specifically for athletes. FORZE GPS nutrition bars utilize a multi-patented blend of healthy fats, protein and calcium that is clinically proven to activate the body’s natural appetite control signal (cholecystokinin or CCK).
FORZE GPS all natural bars are offered in great-tasting chocolate peanut butter and cranberry nut flavors at a suggested retail price of $1.99 per bar. FORZE GPS is available in sports specialty retail stores and online at www.forzegps.com.
About PacificHealth Laboratories, Inc.
PacificHealth Laboratories, Inc. (OTCBB: PHLI - News) is an innovative and leading sports nutrition company that focuses on marketing, developing, and selling premium nutrition products to active consumers seeking to improve their health and performance. Our brands and nutrition tools are segmented into three discreet platforms: rehydration/energy, recovery, and optimal racing weight and include FORZE GPS, the first scientifically proven appetite management tool created specifically for athletes. To learn more, visit www.pacifichealthlabs.com.
volume up, price down, but volume still very low - - around 35K so the day's trading does not spell a trend. Also, the Company is not likely to have news until after the Seattle marathon and expo on June 27. The key here is reorders of the product - - you can give samples and get retail stores and chains to carry you - - but if you don't get reorders you are out of business. That said, there is some correlation between amount of sales to retail that can be traced to the sampling at the marathons, and the likelihood of reorders.
The key to reorders is having a good product that does something special, as Forze does, and making that product available. Forze's plan is to focus on retail and the online will grow along side it.
So, we may be entering a short period of buying opportunity before the Seattle marathon and expo. These events give Forze a lot of focused attention in a short space of time when Seattle is focused on its marathon, and the stock is likely to move up with the attention. At today's closing price of .28 the market cap was 4M, and that is too low a valuation for what PHLI has already put together.
annual meeting well done and about 20 plus shareholders - - tie and jacket crowd - - ten minute dvd about the products which needs work but some of the triathlete spokespersons were very very good particularly one who happens to be a mother of three - - she's beautiful and effortlessly charming - - found out later she didn't start competing until she was in her early 30's and is a former high school teacher. the idea is to first get the elite athlete to use the products then that provides the credibility to attract the next level of athlete - - the marathoners and bikers -- then the daily exercisers, and finally for Forze, the diet market.
some detail about marketing that was interesting: target areas are chosen like southern California and teams of outside sales reps who are specialists in particular sports - - like biking or surfing or running - -then market the entire PHLI line which includes the endurance products like Accelerade and Endurox - - and the ForzeGPS appetite control bars and RTDs. Idea is that the specialty sports stores say for example bike stores are owned by bikers and guys in suits can't sell to them - - but former biker pros can. Not all stores are small or specialized, there are large stores like Ralphs. But the key idea is to use specialized sales reps and to target high potential areas of he country first, like Southern California, Florida etc. - - and of course the places where the Rock n Roll marathons are taking place like the one just in San Diego and the upcoming ones in Seattle, Chicago, San Antonio, Las Vegas etc.
my interest has always been in the diet products - - as much as Forze likes to describe them as appetite control - - for me they are diet products. The RTD is perfect because its calorie content is so low, 50 for the chocolate which stands on its own for taste alone, and 45 for the vanilla which is good tasting but not great. And it works - - it will keep your appetite under control for a couple of hours and its effect is quick. I personally use the RTD as a morning drink to wash down supplements that are supposed to be taken with food and then maybe one or two later in the day, after a workout or when I want a low calorie pick me up - -the drinks contain some caffein, I think about 60mg but not sure. The Forze bars work, but slower than the RTD, and are no great bargain calorically though less than most nutrition bars, but they really taste good and provide good energy.
I didn't mean to go off again about the diet products because the biggest insight I got from the annual meeting was not details of the marketing plan like targeting specific areas of the country with outside reps - - that news has been out there but easier to put together when you hear it from the ceo -- and it wasn't the success so far of Forze in terms of response to the sampling - - that news also has been out there - - but rather the fact that aggressively marketing Forze should help to increase the sales of the already established line of endurance products like Accelerade and Endurox - - it is the branding concept which is the key approach of the ceo - - if you like a product you are more likely to use other products from the same company - - if a store successfully sells Accelerade it is more likely to take on Forze products and vice versa.
annual meeting on June 10 at 10:00 a.m.Hilton Woodbridge, 120 Wood Avenue South, Iselin, NJ- -called company and no webscast but expect overview from ceo. anyone interested who is relatively local to this meeting should go because the key to this company is its ceo - - love the products and without them there is no company, but without this ceo there are no sales
"Where can I buy them?" - FORZE GPS Makes Stellar Debut as the "Official Bar" of the Rock 'n' Roll Marathon Series in San Diego
More Than 50,000 Consumers Sample Product
Jun 2, 2009 10:43:00 AM
Copyright Business Wire 2009
Email Story Discuss on ZenoBank
View Additional ProfilesMATAWAN, N.J.--(BUSINESS WIRE)-- PacificHealth Laboratories, Inc. (OTCBB: PHLI), a leading sports nutrition company, today announced that more than 50,000 consumers sampled the FORZE GPS(TM) nutrition bars at the San Diego Rock 'n' Roll Marathon and Expo, held May 29-31, 2009. The San Diego Rock 'n' Roll Marathon, one of the most popular running events in the nation with over 22,000 runners, marks the first of 19 races featuring FORZE GPS as the "Official Bar" of the Rock 'n' Roll Marathon Series. The next event, a half and full marathon, will be in Seattle on June 27, and is sold out with over 25,000 runners registered.
"Overwhelmingly, the biggest question we had from the consumers who sampled FORZE GPS over the weekend was 'Where can I buy them?' - this is a good indicator of potential future success at this initial stage of the brand's launch." said Jason Ash, CEO of PacificHealth Labs, Inc. "We recently announced an ambitious sampling program to reach more than one million consumers with FORZE GPS in 2009 and the Rock 'n' Roll partnership is a big part of this program. The inaugural event in San Diego drew overwhelmingly positive feedback from attendees. We are very excited at the prospect of reaching an estimated further 2.9 million consumers throughout the balance of 2009 and 2010 with this activity."
In addition to giving FORZE GPS bars to all race finishers, more than 1,000 consumers purchased the product from local retailers at the FORZE GPS booth at the prerace health & fitness expo held on the two days prior to the event. As a result, PacificHealth Labs will be leveraging further retail integration opportunities at all the upcoming Rock 'n' Roll prerace expos, the next being at the Qwest Event Center in Seattle on June 25 -27.
Athletes know that the leaner a body becomes, the greater its potential for speed and performance. FORZE GPS is the first scientifically proven appetite management tool created specifically for athletes. FORZE GPS nutrition bars utilize a multi-patented blend of healthy fats, protein and calcium that is clinically proven to activate the body's natural appetite control signal (cholecystokinin or CCK).
FORZE GPS all natural bars are offered in great-tasting chocolate peanut butter and cranberry nut flavors at a suggested retail price of $1.99 per bar. FORZE GPS is available in sports specialty retail stores and online at www.forzegps.com.
About PacificHealth Laboratories, Inc.
PacificHealth Laboratories, Inc. (OTCBB: PHLI) is an innovative and leading sports nutrition company that focuses on marketing, developing, and selling premium nutrition products to active consumers seeking to improve their health and performance. Our brands and nutrition tools are segmented into three discreet platforms: rehydration/energy, recovery, and optimal racing weight and include FORZE GPS, the first scientifically proven appetite management tool created specifically for athletes. To learn more, visit www.pacifichealthlabs.com.
Notice: This news release and oral statements made from time to time by Company representatives concerning the same subject matter may contain so-called "forward-looking statements". These statements can be identified by introductory words such as "expects", "plans", "will", "estimates", "forecasts", "projects" or words of similar meaning and by the fact they do not relate strictly to historical or current facts. Forward-looking statements frequently are used in discussing new products and their potential. Many factors may cause actual results to differ from forward-looking statements, including inaccurate assumptions and a broad variety of risks and uncertainties, some of which are known, such general economic conditions, consumer product acceptance and competitive products, and others of which are not. No forward-looking statements are a guarantee of future results or events, and one should avoid placing undue reliance on such statements.
Source: PacificHealth Laboratories, Inc.
----------------------------------------------
For PacificHealth Laboratories
Inc.
Kristin Jones
415-955-2607
kristin@JonesPR.net
phli - - stock did well today and that may reflect how the company did at the san diego marathon and expo
San Diego Marathon Health & Fitness Expo
* May 29 - 30, 2009
* Friday: 11 am - 7 pm, Saturday: 9 am - 5 pm
hudson has joined nite on the bid at .29 so there are at least two who want to buy - - probably can get some in the low .30's but i would wait until the ice breaks
someone has been buying a few shares - - low volume though and nite still only mm and i wonder how much they know about the volume on either side of the bid and ask.
if anyone is following this board i welcome any comments or questions. best suggestion if you are interested in the stock is to first buy the forze products online and put them to the test.
this is a classic peter lynch type stock where you can, at least initially, just go on the basis of whether you like the products. if you like the products check out the stock, and if you don't like the products, walk away.
Press Release Source: PacificHealth Laboratories, Inc.
FORZE GPS Named "Official Bar" of the Rock 'n' Roll Marathon Series
Two-Year Agreement Initiates Program to Sample One Million Active Consumers
* On Monday May 11, 2009, 9:00 am EDT
MATAWAN, N.J. & SAN DIEGO--(BUSINESS WIRE)--Competitor Group (CGI), the leader in endurance sports media and event entertainment, and PacificHealth Laboratories, Inc. (OTCBB:PHLI - News), a leading sports nutrition company, today announced that PHLI’s FORZE GPS™ line of nutrition bars has been named the “Official Bar” of the 2009 and 2010 Rock ‘n’ Roll Marathon Series.
The exclusive two-year sponsorship agreement will provide extensive sampling and selling exposure for FORZE GPS, the first appetite management tool created specifically for athletes. FORZE GPS will be given to all participants in the Rock ‘n’ Roll series, sampled at the pre-race health and fitness expos, appear in all Rock ‘n’ Roll Marathon advertising and promotional materials, and will be on signage at over 19 Rock ‘n’ Roll events over the next two years.
Host to some of the largest marathon and half marathon combination events in the world, the Rock ‘n’ Roll Marathon Series consists of events that draw hundreds of thousands of participants annually in key markets such as Phoenix, Chicago, Nashville and San Antonio. The first event FORZE GPS will be featured in is the Rock ‘n’ Roll San Diego Marathon which takes place on May 31, 2009.
“Even in the few short weeks since we launched FORZE GPS we have seen an incredible level of passion for the brand. Most notably, the feedback has focused on the remarkable combination of both taste and performance,” said Jason Ash, CEO of PacificHealth Laboratories, Inc. “Getting the product into people’s hands is the key to that passion and we are today announcing our ambitious sampling program to reach more than one million active consumers with the product. Our partnership with the Competitor Group to be the ‘official bar’ of the Rock ‘n’ Roll Marathon Series, the biggest aggregate number of marathon and half marathon runners in the world, is a key component to reaching that goal.”
“The Competitor Group takes pride in identifying and partnering with innovative companies across both our event and media platforms,” said Scott Dickey, COO of the Competitor Group. “The Rock ‘n’ Roll Marathon Series is known for bringing active lifestyle enthusiasts and products together at our world-class health and fitness expos. It is only natural for the premier series of national running events to associate with brands and products that deliver value to our participants, and we're excited to partner with FORZE GPS to reach their goal of sampling one million active consumers.”
Athletes know that the leaner a body becomes, the greater its potential for speed and performance. FORZE GPS is the first scientifically proven appetite management tool created specifically for athletes. FORZE GPS nutrition bars utilize a multi-patented blend of healthy fats, protein and calcium that is clinically proven to activate the body’s natural appetite control signal (cholecystokinin or CCK) with as few as 45 calories per serving.
FORZE GPS all natural bars are offered in great-tasting chocolate peanut butter and cranberry nut flavors at a suggested retail price of $1.99 per bar. FORZE GPS is available in sports specialty retail stores and online at www.forzegps.com.
About The Competitor Group
Competitor Group, Inc., headquartered in San Diego, CA, is the leading media and event entertainment company dedicated to the endurance sports industry of running, cycling and triathlons. CGI is a portfolio company of Falconhead Capital and comprised of the following brands: Competitor Magazine, Triathlete Magazine, Inside Triathlon, VeloNews, the Rock 'n' Roll Marathon Series, Muddy Buddy and VeloPress. CGI owns and operates 26 national events delivering more than 250,000 professional and amateur participants in 2009. CGI publishes four magazine titles with a combined monthly circulation of approximately 1 million and plans to launch an endurance community web presence under competitor.com in Q2 2009. Further information about Competitor and its media properties can be found at www.competitor.com.
About PacificHealth Laboratories, Inc.
PacificHealth Laboratories, Inc. (OTCBB:PHLI - News) is an innovative and leading sports nutrition company that focuses on marketing, developing, and selling premium nutrition products to active consumers seeking to improve their health and performance. Our brands and nutrition tools are segmented into three discreet platforms: rehydration/energy, recovery, and optimal racing weight and include FORZE GPSM, the first scientifically proven appetite management tool created specifically for athletes. To learn more, visit www.pacifichealthlabs.com.
Public Reply | Priv
PacificHealth Laboratories Reports First Quarter 2009 Results and Updates Launch of ForzeGPS
* On Wednesday April 29, 2009, 1:51 pm EDT
MATAWAN, N.J.--(BUSINESS WIRE)--PacificHealth Laboratories, Inc. (OTCBB: PHLI - News), a leading nutrition company, today reported its financial results for the quarter ended March 31, 2009 and issued an update on the launch of ForzeGPS™, the Company’s new appetite management control tool for athletes.
First Quarter 2009 vs. First Quarter 2008 Financial Results
Revenue was $1,695,618 compared to $1,719,375 for the same period in 2008. Net loss for the first quarter was $405,465, or $0.03 per share, compared to a net loss of $271,405, or $0.02 per share, for the same period in 2008. Included in the net losses above are non-cash equity instrument-based expense of $69,498 and $109,262, respectively, for the periods ended March 31, 2009 and 2008. Sales and marketing expenses increased $171,874 in the quarter ended March 31, 2009 compared to the same period in 2008 primarily due to increased spend associated with the introduction of a new national sales representative organization designed to increase penetration in the sports specialty retail market and for a public relations and marketing campaign associated with the launch of ForzeGPS. General and administrative (“G&A”) expenses decreased $67,824 in the quarter ended March 31, 2009 compared to the same period in 2008, primarily due to the organizational restructuring initiated in the third quarter of 2008.
Jason Ash, President and Chief Executive Officer of PacificHealth Laboratories said, “With revenue down slightly from the prior comparable period in 2008 largely attributable to the challenging economic environment and with retailers in particular shifting to much tighter inventory controls, the demand aspects of our base sports performance business are holding up well. The management team continues to focus on increasing gross margin, maintaining marketing efficiency and containing G&A expenses as we continue to drive prudent cost savings measures throughout the Company. We will be clear of the restructuring cost overhang in the third quarter. We ended the quarter with 14.5 million shares outstanding, approximately $800,000 in cash and other short-term investments, a $15.1 million federal net operating loss carryover (which has been fully reserved), and only $30,000 of debt. We significantly increased consumer marketing expenditures in the quarter, reflecting our commitment to the launch of ForzeGPS in support of our new route to market.”
Mr. Ash continued, “The launch in March of ForzeGPS, the first appetite management tool designed for athletes, has gone extremely well in just a few short weeks. Key influencers in the sports specialty class of trade and the athletic community have wholeheartedly embraced our new approach to the sports performance category and weight control objective. Sales have already exceeded our previous endeavors in the weight control field. We expect to announce further details of our marketing efforts for ForzeGPS in the coming weeks.”
THE IRONMAN OF MARKETING
For triathlete Jason Ash, branding is just another race to run -- and win
By Kenneth Hein, Brandweek
(Photo by Aaron Kotowski)
Even in a sensory-overload place like New York's Times Square, a one-of-a-kind spectacle went down on the afternoon of June 21, 2007. High above Seventh Avenue, in a niche of the Reuters Building, a shirtless guy was casually trotting along on a treadmill, oblivious to the thousands of people staring up at him.
A launch of a new athletic shoe? A promo for expensive workout equipment? Not quite. It was the kickoff of Cadbury Schweppes' $50 million blitz for Accelerade, the ready-to-drink sports beverage that was presumably helping über-athlete Dean Kamazes -- he was the shirtless guy -- set a world's record for the 24-hour endurance run.
It was a proud moment for Jason Ash, then the 33-year-old general manager of Cadbury's sports, energy and water business-but a moment was all it was. Soon afterwards, Cadbury switched strategy and sold off Accelerade, and the young Ash's plans along with it.
Most would find the failure crushing, but Ash was not about to give up. He believed in Accelerade's protein-rich line (it might be because Ash happens to be an Ironman athlete himself). Initially hoping to sublicense the New Jersey-based brand's pills, powders and gels from the U.K, Ash changed his plans after PacificHealth Labs chairman Robert Portman asked him: "Why not just move here and do it? "The consumer strategy for the business was not optimized," Ash recalls. "I was being given the chance to do it on the big playing field in the U.S." He accepted.
As far as marketing the brand went, well, Ash had already had a few ideas about marketing. As a student at the University of Durham in England, he'd made a tidy sum by signing up local pubs to advertise in leaflets he then crammed into fellow students' pigeonholes (American translation: mailboxes). Ash's plans to "take the business to London and obliterate the leaflet market," however, were detoured by a stint as a pro rugby player. But Ash cut that gig short, figuring he should "probably learn how to use a calculator." He went to work for food giant Unilever where, before long, he found himself promoted to brand manager of Marmite.
A spread made from yeast extract, the shoe-brown, salty, tar-like condiment is either loved or loathed by Brits. And it was this very theme that Ash graphically (and, by consensus, hilariously) harnessed for a TV spot in which a nerdy guy's dream-come-true kiss with a beautiful woman is ruined (he breaks into a fit of retching) because she's just eaten some Marmite. The commercial would win Unilever its first BATT gold award in seven years.
Things moved quickly for Ash after that. His work for Unilever got him poached by rival Masterfoods. Ash's creation of an explosively popular pouch-packaged "express rice" product for Uncle Ben's in turn got him poached by Cadbury Schweppes. In 2002, Ash went to work on candy brand Bassett's. He gave Bertie Bassett, the brand's candy-man mascot first introduced in 1929, a computer-generated makeover while simultaneously launching the "Allsorts" line extension.
The success of both within his first year at the company landed him a promotion overseeing the firm's business in Istanbul, Turkey. A year after that, Ash found himself in Texas as the marketing director of Dr Pepper North America. There, he helped push through the brand's first major repackaging in about 10 years. But soon, Ash would be assigned the task of tackling the growth areas of the beverage business heading up its sports, energy and water portfolio. And, well, we know how that ended.
Today, at 34, Ash is notching his second year at PacificHealth, which has licensed Accelerade back from Dr Pepper. Accelerade sells at leading retailers including GNC and Vitamin Shoppe, but according to Gerry Khermouch, editor of Beverage Business Insights, the drink still has plenty of untapped potential. "Certainly there seems to be an undercurrent of consumer disenchantment with existing sports drinks that some of the more protein-oriented marketers may be able to tap into," he says. Not one to sit out a race, however, Ash has moved on to develop other sports beverages. He's at work on the launch of one called ForzeGPS, an appetite suppressant that comes in a liquid form aimed squarely at Slim-Fast and Muscle Milk. "It's a great opportunity to expand the business," he says.
In a short but successful career, Ash has already done a good deal of that sort of thing. But what about that dream of dominating the leaflet business? "I've managed to let that one go," he says.
stock has gone up 20% this week on nothing to speak about volume, but a buyer has clearly come into the stock and that is a pleasure to see. the key for phli is to get people to taste its products and feel their effects -- so i am really looking forward to the san diego marathon next week with 25k runners getting a taste.
so i think sales are going to explode, can't put it any other way, but not sure how able the company will be to get those who taste and order the products to follow the dots from product to stock. we'll see. if my back wasn't out i would go see for myself -- i have a position that would make it worthwhile to see first hand.
i wonder if anyone is reading this board. i have done no advertising of it. glta
if anyone is following this stock the first rock n roll marathon takes place in san diego on may 31 and phli is giving out forze bars to all 25k runners and selling its entire line of sports drinks and forze products at the expo. it should be a very big event for phli because this is the first marathon in the rock n roll series that is sponsored by phli. but will phli publicize it?
that is a real question because it has no professional ir and though the ceo is a marketing whiz, the stock market is not yet his game. so if you have an interest in this stock, please post on this board and i will make sure he gets the message.
my suggestion for anyone who might be interested in this stock is to order the products and decide for yourself whether phli is going to be able to make money selling them - - the bars are incredibly good and the vanilla drink passable in taste but well worth the 50 calories and appetite effect. that's the nice thing about a consumer products company - - you get to be the judge. and right now there is a wide spread in phli that i am sure will narrow if there is some action, but once the san diego marathon takes place and there is some data to judge the marketing plan, i think there will be lots of action - - in part because the company is no doubt going to promote its stock at the same time it is marketing its products.
the key for me is that the expos at each marathon where the different products are sold is constructed so that each marathoner has to pass through to register on the day of the race.
there just are not that many shares available with an o/s under 15m and insiders controlling about half. key test will be the first marathon sponsored which takes place in san diego on may 31 - -key in the sense of the marathoners reaction to the bars, to the company's sales of its entire line of products at the marathon expo,and the company's ability to pr the event before and after.
i am not sure that the company intends to cc the annual meeting and it might help push it in that direction if emails were sent to the ceo. he is responsive to the market, though still learning about it, and if phli is going to have any chance it will be because he is something of a marketing prodigy. see the article in adweek about him from a week or so ago.
this is big news that the market has greeted with a yawn. it is big because the exposure for phli and its brands is going to be huge, and if successful a company maker of huge proportions since the best way to sell bars and drinks is to get people to taste them, and what better envirnment for that than marathons.
the scary part is it is a bet your company approach. if it fails that's it for phli.
positive is low o/s. negative is insiders just don't buy. really hard to understand when the stock is in the teens.
i am long the stock and like the forze bars and drink. the bars taste extremely good, the vanilla drink is passable but does have a very profound appetite control effect for 50 calories and is all natural. unfortunately the chocolate which tastes much better (samples of the products were given out at the edgewater micro-cap investment conf in march and i had a chance to taste the chocolate)ran into a manufacturing hitch and is not yet available.
FORZE GPS Named "Official Bar" of the Rock 'n' Roll Marathon Series
Two-Year Agreement Initiates Program to Sample One Million Active Consumers
May 11, 2009 9:00:00 AM
Copyright Business Wire 2009
Email Story Discuss on ZenoBank
View Additional ProfilesMATAWAN, N.J. & SAN DIEGO--(BUSINESS WIRE)-- Competitor Group (CGI), the leader in endurance sports media and event entertainment, and PacificHealth Laboratories, Inc. (OTCBB:PHLI), a leading sports nutrition company, today announced that PHLI's FORZE GPS(TM) line of nutrition bars has been named the "Official Bar" of the 2009 and 2010 Rock 'n' Roll Marathon Series.
The exclusive two-year sponsorship agreement will provide extensive sampling and selling exposure for FORZE GPS, the first appetite management tool created specifically for athletes. FORZE GPS will be given to all participants in the Rock 'n' Roll series, sampled at the pre-race health and fitness expos, appear in all Rock 'n' Roll Marathon advertising and promotional materials, and will be on signage at over 19 Rock 'n' Roll events over the next two years.
Host to some of the largest marathon and half marathon combination events in the world, the Rock 'n' Roll Marathon Series consists of events that draw hundreds of thousands of participants annually in key markets such as Phoenix, Chicago, Nashville and San Antonio. The first event FORZE GPS will be featured in is the Rock 'n' Roll San Diego Marathon which takes place on May 31, 2009.
"Even in the few short weeks since we launched FORZE GPS we have seen an incredible level of passion for the brand. Most notably, the feedback has focused on the remarkable combination of both taste and performance," said Jason Ash, CEO of PacificHealth Laboratories, Inc. "Getting the product into people's hands is the key to that passion and we are today announcing our ambitious sampling program to reach more than one million active consumers with the product. Our partnership with the Competitor Group to be the 'official bar' of the Rock 'n' Roll Marathon Series, the biggest aggregate number of marathon and half marathon runners in the world, is a key component to reaching that goal."
"The Competitor Group takes pride in identifying and partnering with innovative companies across both our event and media platforms," said Scott Dickey, COO of the Competitor Group. "The Rock 'n' Roll Marathon Series is known for bringing active lifestyle enthusiasts and products together at our world-class health and fitness expos. It is only natural for the premier series of national running events to associate with brands and products that deliver value to our participants, and we're excited to partner with FORZE GPS to reach their goal of sampling one million active consumers."
Athletes know that the leaner a body becomes, the greater its potential for speed and performance. FORZE GPS is the first scientifically proven appetite management tool created specifically for athletes. FORZE GPS nutrition bars utilize a multi-patented blend of healthy fats, protein and calcium that is clinically proven to activate the body's natural appetite control signal (cholecystokinin or CCK) with as few as 45 calories per serving.
FORZE GPS all natural bars are offered in great-tasting chocolate peanut butter and cranberry nut flavors at a suggested retail price of $1.99 per bar. FORZE GPS is available in sports specialty retail stores and online at www.forzegps.com.
About The Competitor Group
Competitor Group, Inc., headquartered in San Diego, CA, is the leading media and event entertainment company dedicated to the endurance sports industry of running, cycling and triathlons. CGI is a portfolio company of Falconhead Capital and comprised of the following brands: Competitor Magazine, Triathlete Magazine, Inside Triathlon, VeloNews, the Rock 'n' Roll Marathon Series, Muddy Buddy and VeloPress. CGI owns and operates 26 national events delivering more than 250,000 professional and amateur participants in 2009. CGI publishes four magazine titles with a combined monthly circulation of approximately 1 million and plans to launch an endurance community web presence under competitor.com in Q2 2009. Further information about Competitor and its media properties can be found at www.competitor.com.
About PacificHealth Laboratories, Inc.
PacificHealth Laboratories, Inc. (OTCBB:PHLI) is an innovative and leading sports nutrition company that focuses on marketing, developing, and selling premium nutrition products to active consumers seeking to improve their health and performance. Our brands and nutrition tools are segmented into three discreet platforms: rehydration/energy, recovery, and optimal racing weight and include FORZE GPSM, the first scientifically proven appetite management tool created specifically for athletes. To learn more, visit www.pacifichealthlabs.com.
Notice: This news release and oral statements made from time to time by Company representatives concerning the same subject matter may contain so-called "forward-looking statements". These statements can be identified by introductory words such as "expects", "plans", "will", "estimates", "forecasts", "projects" or words of similar meaning and by the fact they do not relate strictly to historical or current facts. Forward-looking statements frequently are used in discussing new products and their potential. Many factors may cause actual results to differ from forward-looking statements, including inaccurate assumptions and a broad variety of risks and uncertainties, some of which are known, such general economic conditions, consumer product acceptance and competitive products, and others of which are not. No forward-looking statements are a guarantee of future results or events, and one should avoid placing undue reliance on such statements.
Photos/Multimedia Gallery Available: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=5960921&lang=en
Source: PacificHealth Laboratories, Inc.
----------------------------------------------
Media:
PacificHealth Laboratories
Kristin Jones
kristin@jonespr.net
or
Competitor Group
Dan Cruz
619-925-7671
dcruz@competitorgroup.com
Some coverage in (mostly) Women's magazines on Satiatrim (yay):
http://www.satiatrim.com/satiatrim-in-media.php?utm_source=Publicaster&utm_medium=email&utm_campaign=All+April+Emails
LOL, I'll try. Guess it is at least nice to see the shares stop the selling trend for now. The company clearly has some issues to get through, and they're not as fiscally tight as I like companies to be. But the products and in particular Mr Ash I think give some reason to at this point hope things get better. It will take time though to see if they can get themselves balanced to stop the cash burn and get back to profitability while tyring to build on growth.
I still think itnernational sales, based on the annual report, represent a nice segment to grow the biz moving forward. Especially with the weakazz dollar continuing to nosedive off the nearest cliff.
I'm reading, and probably so are the others. We just want to know at what point you start answering yourself. LOL
Talking to myself here, with 9 boardmarks I'm assuming they are from people that forgot to remove them LOL.
It'll be interesting going forward to see how well the company can continue to grow the international business, I think Mr Ash will help that segment with his international sales background.
Although costs are increasing for production, the weaker dollar also makes the cost to international customers cheaper. And with web ordering, the convenience is there for international customers so hopefully sales can continue to grow meaningfully in that still very small but also quickly growing segment.
I'm sticking with this one and adding here and there simply becasue I like the products and current valuation. I think Dr Portman has a bit of history with overestimating potential, but such is life when you're the leader. Probably everything looks optimistic.
Hopefully Mr Ash helps target international sales better. He obviously has international sales experience. That could help with the backdrop of a weak US dollar making products cheaper to international customers (since products made and priced in US $). The following table clearly shows international sales were the strongest growth segment of over 35% (although relatively small still) and that was WITHOUT Mr Ash :
The following table presents revenues by region:
2007 2006
United States $ 6,778,183 $ 5,751,148
Canada 208,649 178,556
Other 441,025 280,142
Total $ 7,427,857 $ 6,209,846
Remember PHLI has several international rights/patents to sell Accel gel and powder.
So this could potentially be a nice growth segment for them on % basis but not a big dollar segment yet.
Here's Ash's bio (the international saels part hopefully coming into play):
JASON ASH, age 33, has served as President, Chief Operating Officer, and a Director since January 2008. Prior to joining the company, Mr. Ash worked internationally for Cadbury Schweppes in broad commercial management and consumer marketing, most recently as General Manager and Vice President of Cadbury Schweppes Americas Beverages (“CSAB”) Sports, Energy & Water Category Unit. Mr. Ash has served in various positions at Cadbury Schweppes both in the USA and Europe since 2002. During his tenure, Mr. Ash was responsible for the strategic development and commercialization of the growing Sports Energy and Water pipeline of CSAB in North America as well as a number of key business-changing roles in the UK, Turkey and Middle East. In addition to his considerable experience at Cadbury Schweppes, Mr. Ash has also held Marketing and Finance positions at Masterfoods and Unilever and his work has been nominated for a number of marketing industry awards.
All this said, I still think Portman is not my type of CEO (a cheapo running a tight fiscal ship LOL). His car allowance alone would have Buffett squawking:) But there's still some potential opportunity IMO at this level IMO only with patience.
GSK is apparently still holding their shares if I'm reading the 13G filing correctly. Thought that was slightly interesting (not mroe so because they've held the same shares for eyars apparently, but they did have a chance to sell at levels that would have made more sense to them last year and apparently did not- maybe thye forgot they had them LOL).
Not sure about that but it looks like they've still got the shares (GSK). Plus Diker added a few over the year. Not a big deal but I'l take i t..
Everyone is gone LOL. Not me. Mr Portman is an eternal overoptimistic man. But I think Mr Ash is going to bring a nice sense of balance to the comapny, being a medium fish in the giant ocean vs Dr Portman's probably bigfish in little lake feel.
Extremely competitive industries for their major products, but I have tried the products and like them (Satiatrim and Accel at least, although only the RTD for Accel).
So I'll stay here and keep talking to myself:)
Been nibbling a little in the $0.4s here and there supporting the bid.
I think in a year's time when Accel sales help support the foundation of the comapny that things will start looking better.
Cash burn wasn't that bad last Q. Just the EPS # stunk (more writeoffs from Satiatrim).
Guess I'm a real die-hard lOL, both the moderator and other assistant have left the building...
BUT I'M STILl HOLDING THE FLAG.
Ok, enough soliloquy.
I'm nibbling at the bid here a little. I think the cash flows last Q weren't that bad considering the loss reported. The salary hit will make the front half of 08 tougher from the new additions. But I still tend to give some nod to the products side of this company.
Pricing is a bit of issue. If they could get more competitive there I think some better traction would occur.
But rgeardless, I think they'll be able to start targeting niches for their products a bit better. Sounded like they're starting to see a specific group gaining traction with Satiatrim. Maybe that'll help establish a bit of base. They need a reliable recurring base. I was hoping Accel RTD royalties would be that, but now that looks to not be the case.
Therefore, I'm just nibbling for now being a little fish.
Well looks like we lost zen, and I'm not sure but believe cl001 sold out awhile ago (hopefully at a profit). I'm here though.
The call went OK, I did like Mr Ash's kind of macroview. You can tell he's 'adjusting' for lack of a better word to a smaller comapny. But he's getting paid a lot of $.
At least they mentioned they are looking to be profitable for 2008 and that's with the excess salaries from the newbies obviously included.
But they still need to prove it. The Q4 was another semi-yuk Q. Lost I think another 4 cents. But cash held up pretty well and hopefully the last of Satiatrim writedowns was a big chunk of the loss.
The growth in rack sales and their targeting this strategy sounds like a decent idea for a base to grow off of.
Still lots left for them to prove though. And it definitely sounds like CSAB cut back fairly bigtime on the advertising looking more toward the grassroots stuff.
I'm holding what I have but not buying more at this juncture. Need to see more proof in the pudding.
I have none (very little info). GOOG search didn't turn up much other than he apparently was a writer for PSU's paper. I'm curious what his contract terms are (salary). It'll be good to hear from them both on the 12th.
With PHLI, I'm not at all pounding the table or anything (not yet anyway). However, they have a couple products that I think can sell with more effective marketing (Zen has clearly brought this up before and their inability to successfully market).
The question now is can these two new guys become very effective marketers? There's more risk now in some ways because of the cost to us shareholders with the two new additions both in cash burn and in share/option dilution (unless you're buying down here, then it aint dilutive yet)).
Mr Ash is getting a CEO salary, moving expenses, and a very healthy options package. That is what it takes sometimes to draw in people I guess. But it makes me think Mr Ash is coming to the company based on his own financial well being (not blaming him) and not necessarily out of a strong draw to Accel and Satiatrim. I'd be curious what he was getting paid at CSAB....
I do however think that even if CSAB drastically cut spending on ads for Accel (based on test market sales that may very well be the case) that there's at least a fair amount of branding power starting to build for the powder and gel forms. Plus there's the whole protein muscle recovery angle that has gained momentum in the last few years. So I think there's a decent chance of seeing growth in that segment for some time.
Satiatrim is more a wild card in a highly competitive and highly marketed area (of ocurse lots of $ spent by consumers there too)- weight loss and appetite suppression. So I'm not clear on how things might go with that product moving forward.
For now, this could go either way so I'd say there's a fair amount of risk. But with the Accelerade name and the current market cap, I think this is a good place to speculate on a small-moderate position even with the unknown future.
In the near term, I would guess they'll struggle a bit. But after that, they have some opportunity if they can successfully market.
It'll be interesting to see how the meet and greet goes. Nice to have the company do that.
As far as balance sheet, they have the healthy cash but are burning some of it with the additions to the staff. Hopefully in a couple/few Qs we'll see some direct positive impact from these guys:)
I'll be trying to learn more about Mr Ash and establishing communication with him going forward hopefully.
All IMO, good luck.
Hey fish, what's your take on this company? What gives with the falling pps?
Your other pick is kicking arse, just thought i'd ask. Never know what you may find.
No idea yet. Haven't had a chance to check much, but seems like he was a staff writer at PSU until very recently (so was he working and attending school simultaneously, mayeb to get hid Masters? I'm guessing so- but the PR seems to maybe overstate things in that how involved would he be as a VP of products in a restructuring and then acquisitional deal?)). I'll hopefully talk to Mr Ash in a couple weeks.
Good luck.
Littlefish, What do you think of the new hire announced in the press release today? Do you have any info on the guy?
I bit off a few more shares of PHLI before the stubborn ask at $0.57 yesterday got taken out. That ARCA MM was the only MM on the ask at $0.57 for awhile, but it was someone with a sizeable order that was finally swallowed up.
Now that we cleared up that apparent seller and with tax loss selling behind us, maybe we can wiggle back up a bit.
But as mentioned previously, I'm not expecting any fireworks soon. The price increase may help margins a bit going forward (or at least offset price increase for shipping and in whey protein price increases). But it'll take time for Accelerade to get more traction IMO and Mr Ash will probably take a bit of time to show us what he can do.
But the building blocks going forward look like they're starting to take shape.
Nice to at least clear the selling pressure for now.
Several things caused the drop IMO. For one, RTD sales of Accelerade have been very disappointing IMO and I think maybe CSAB will cut back their projected spending for the product (possibly extensively).
So Accelerade branding power becomes a bit weaker IMO.
Plus the company made too much Satiatrim on the initial (official) launch that will or has expired (thus the write-off, but it is behind us now). Apparently the company (and many shareholders) expected things to happen quickly with the Satiatrim product.
Then you have a little momentum selling toward the end of the year. And Gross Margins have not improved as much as I was hoping considering the decent 20% revs growth.
We'll have to see what Mr Ash can do for the company. At this stage, he's more a liability than an asset only in terms of whatever he can do for the company will take a little time IMO and his costs to the company start January 3. So Q1 2008 should have some extra expenses with him coming onboard. But he does seem to be a nice catch. Young, holding a fairly important position at CSAB previously (is he British?).
I'll try and get in touch with him once he gets settled in to try and get a little feel on how he sees things. He'll probably need some time though to get settled in so I'm not gonna push to hear from him right away.
With book value around $4 mill and market cap around $7 mill right now and some insider buying activity, I think this makes an OK place to start building a position ahead of seeing how things turn out.
The branding power of Accelerade should be a nice buffer and worth something to the intrinsic value of the company too going forward. At this point though, it is hard to gauge the true value of Accelerade.
I'm not giving much value to Satiatrim at this juncture in my thoughts on what the company is worth (it has been a liability not asset so far IMO)...
Just tryiong to be realistic.
Nice to get another poster here! LOL, maybe we can wake the dead and get some talk going with PHLI again now that it is heavily discounted.
Good luck.
I bought in a few years back at .90/share. I watched it go all the way up over $3 and all the way back down. I wish I would have sold a few shares at that time but got greedy thinking it would continue to rise. What caused the drop-off? I heard rumblings that Cadbury wasn't too satisfied with how Accelerade RTD was doing in retail outlets? Do you have any insight into this matter?
Some things to ponder from last 10Q:
Deferred revenue increased as a major customer took on additional products and increased its inventories in the third quarter of 2007 as compared to the fourth quarter of 2006. In addition, we issued common stock in connection with sales of common stock and exercises of options and warrants resulting in proceeds of $726,036 during the nine months ended September 30, 2007.
S, G, & A expenses increased primarily due to the investment in marketing and other expenses of $88,449 and $276,167 respectively, for the three- and nine- month periods ended September 30, 2007 associated with the launch of SATIATRIM. We expect to continue to invest in the marketing of SATIATRIM. Late in the second quarter, we officially launched the product via a major public relations campaign that involves the Internet, radio, television, and print media.
For the three months ended September 30, 2007, gross profit margin on product sales was 43.9% compared to 44.9% for the three months ended September 30, 2006. For the nine months ended September 30, 2007, gross profit margin on product sales was 39.7% compared to 47.3% for the nine months ended September 30, 2006. We experienced a change in our product mix. Also, in order to fully take advantage of the CSAB advertising spend, we redesigned all ACCELERADE and ACCEL GEL packaging to conform to the new CSAB ACCELERADE RTD packaging. To flush out old inventory, we aggressively discounted these products, leading to lower gross profit margins. We wrote off approximately $49,000 of non CSAB-type packaging material, which is the equivalent of 0.8% of the nine-month revenues. We experienced cost of production and raw material price increases, specifically whey protein, in our finished products from 2006 to 2007. We also experienced a significant increase in freight costs coupled with our decision to provide free freight to more customers as a sales incentive. To address these issues, we implemented our first ever price increase effective July 1, 2007. This price increase met no resistance in the market place.
Personally, I think the company would be stronger today if it had never tried to launch Satiatrim. But I've tried the product and think it has some merit as far as I think it cuts down on my snacking. Not sure about direct weight loss, but there seems to be a bit of effect IMO.
Still like this one though for the Accelerade powder and gel sales.
Gross margins haven't perked up even with approx 20% increased sales, and the addition of Mr Ash will likely keep pressure on GMs in the short term IMO for early 2008 (his salary and incentives).
Maybe we'll see some traction build with Satiatrim. They obviously were way too aggressive in estimating sales and that inventory writedown hurt the bottom line (although they did put some of it to use placing it to prospective clinets apparently).
But that's behind us now. Insiders are dabbling with more shares, although Mr Cahr hasn't joined in (recently) yet.
The expense of RTD Accelerade is certainly a deterrent for competing directly with the Powerades and Gatorades of the world.
But there's a niche market for it for sure. And the powder and gel sales IMO could help provide a cheaper alternative to that niche market segment.
Considering Q4 is often seasonally a bit weaker, I would think we might see a semi-slow 1st half to 2008. But with Mr Ash about to start, some marketing spending done for Satiatrim to help with hopefully a little traction, the write-downs for old packaging done, the implemented price increase, and Accelerade brand awareness helping a bit going forward things may look to turn around for PHLI going into 2nd half of 2008 and I htink it looks attractive at current levels.
Anybody else around here? Or has everybody abandoned ship.
PHLI- OK, I'm gonna start digging on PHLI and maybe building a bit of a position at these levels but it may take about a week to start digging more on this. From my skimming, there's some dilution on the way up with Mr Ash on board, but he seems to be a young quick mover in the biz sense. He defected from CSAB to PHLI so IMO must see something and is keeping good ties with CSAB as far as Accel goes (although PHLI gave some very attractive incentives to lure him that may cost shareholders in the short term, including his $50 thou plus moving expenses and car allow this year and $40 thou or so next if I recall plus the bonus options, etc).
Mr Ash's options though are at higher levels than current share price. Plus Portman and others were basically all paying more than current levels for their shares so their acquiring is accretive for us down here. They now have 7 directors, with a bit more diversity. They have enough cash to handle things IMO with about break-even results last Q if you factor out the 1-time writedown of Satiatrim.
Tangible Book value is close enough to current market cap to provide some downside protection IMO.
If I get in bigger though it is because of Accel IMO. Satiatrim may or may not be helpful going forward. But I htink Accelerade powder and gel sales have little market penetration currently and may carve out a decent niche going forward.
Lots of digging to do though.
And not at all pounding the table, as there are bigger fish in this with much more knowledge IMO than any of us have about the company... But there has been continued support from insiders buying to some degree.
Might be a bit of year-end selling pressure to keep it down here (is this a new low today for the year?).
One nice small thing on the balance sheet is the deferred revs figure is growing a bit and is counted as a liability;) Nice to see those things on the balance sheet growing, even if it is small...
Anybody know who their big customer is? Zen- do you know? It has been awhile since I spent much time looking at this one.
Good luck.
PS- let's resurrect this board! This is a better investment down here IMO and is looking pretty good IMO only. I'll wait for Mr Ash to settle in and see if I can contact him to get a feel for things through his eyes. I'm curious of his feel/perspective on things going forward for PHLI's powder and gel sales...
PacificHealth Laboratories, Inc. Provides Update on Business
Monday October 15, 9:00 am ET
MATAWAN, N.J.--(BUSINESS WIRE)--PacificHealth Laboratories, Inc. (OTCBB: PHLI - News), a nutrition technology company, provided today an interim third quarter update on their business.
Dr. Robert Portman, President and CEO, said, "Sales results for our sports nutrition products continued to remain strong in the third quarter. We expect to show 20% growth in revenues from the same period in 2006. The growth in our sports nutrition products can be attributed both to the advertising and promotional efforts by Cadbury Schweppes Americas Beverages ("CSAB") in support of Accelerade RTD as well as the continued success our rack, direct internet and other programs have had in expanding distribution and same store sales among sports specialty retailers. The number of total Accelerade servings sold in the third quarter is the highest we have ever seen for this product. This strongly suggests that our audience of users is expanding. While Cadbury Schweppes has publicly announced their disappointment in sales of Accelerade RTD to date, we are encouraged by our own increase in sales and we will continue to work closely with the CSAB sales and marketing team."
Dr. Portman continued, "In the fourth quarter we will initiate a number of marketing and sales efforts for Satiatrim including the launch of radio commercials and ads in Women's World as well as the initiation of a major sampling program to put trial product in the hands of our target audience. We should begin to see the results of these efforts in the fourth quarter."
Dr. Portman added, "At the Obesity Society Annual Scientific Meeting in New Orleans this month, a study will be presented showing the effectiveness of Satiatrim on slowing gastric emptying. I am also extremely excited about some of our latest research results from Hope Hospital in Manchester, England. These results are laying the foundation to allow us to incorporate the Satiatrim technology into new forms and to develop new products that are even more efficacious with a greater duration of action."
Places you can find Accelerade :
24 Hour Fitness
7-Eleven
Acme
Albertsons
Bashas'
Dominick's
Food Lion
Gelsons
G.N.C.
H.E.B.
Kroger
Longs Drug
Market Basket
Plaid Pantry
Publix
Quik Trip
Ralphs
Randalls
REI
Safeway
Shaw's
ShopRite
Target
Tom Thumb
Vons
Winn Dixie
What happened the last to days... We were at $3.19 eod on Monday
WEEEEEEEEEEE!!! CHART:
not me thats for sure
b/c of stupid stocks
HELLO??? IS ANYONE ELSE MAKING MONEY HERE WITH ME???????
this stock is making a HUGE MOVE right now!!! WOW!!!!
just saw a banner ad on pogo.com
http://www.accelerade.com/products/Default.aspx
Followers
|
8
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
124
|
Created
|
10/14/06
|
Type
|
Free
|
Moderators |
PHLI is a sports nutrition company that creates and markets nutrition products for exercisers and athletes seeking to improve their health and performance. Products include ENDUROX EXCEL, a dietary supplement, ENDUROX R4, a recovery drink, ACCELERADE, a sports drink, ACCEL GEL, an energy gel - - and the recently launched ForzeGPS, the first scientifically formulated appetite control tools created specifically for athletes. ForzeGPS products consist of bars in two flavors, chocolate peanut butter and cranberry nut; and RTDs in vanilla and chocolate. The RTDs are 50 calories for the chocolate with one carb, and 45 calories for the vanilla with no carbs. The bars are 160 calories, and like the RTDs contain a patented blend of healthy fats, protein and calcium that stimulate the bodiy's production of the peptide CCK.(Cholecystokinin) which triggers a sense of not being hungry without feeling full. There is a wealth of excellent scientific information at forzegps.com.
PHLI currently sells its products online and through over 8,000 specialty sports and bike stores, though not all products are sold at all the stores.
CEO Jason Ash was the general manager of Cadbury's sports, energy and water business before becoming CEO of PHLI. A former pro rugby player and current triathlete, the 34 year old CEO was recently profiled as the "Iron Man of Marketing" in the May 2, 2009 editions of Adweek and Brandweek.
O/S under 15M, fully diluted under 16M
Insiders own about 38%.
Average daily trading volume last three months under 20K
What to watch for: PHLI is a sponsor for the next two years of the Rock n Roll marathons. The first was held in San Diego on May 31, 2009, and over 50,000 consumers sampled the ForzeGPS bars. The next event is a half and full marathon in Seattle on June 29. There is a complete list of this year's races below. The ForzeGPS bars will be given out to the 25,000 runners who have regisered for the Seattle marathon, and the entire line of ForzeGPS and PHLI products will be available for sample and sale at the pre-race health and fitness expo which are held for two days prior to the race and on the day of the marathn. http://finance.yahoo.com/news/FORZE-GPS-Named-Official-Bar-bw-15198631.html?.v=1
Company Positives: The ForzeGPS RTDs are a no-brainer from a calorie and carb content point of view, work very effectively to control appetite, taste good, and are beautifully packaged. The ForzeGPS bars are truly delicious, have an energy boost effect, and also control appetite but are not as quick acting as the RTDs. Another positive is the Company's existing sales to over 8,000 sports specialty stores and bike shops, of which about 10% have racks specifically for some of PHLI's products. There is also an attractive website for online sales. Most important, the Company now has an aggressive sales oriented CEO who has a record of success, and who has assembled a talented team of Atkins alumni..
Company Negatives: If the sponsorship of the Rock n Roll races works, and there is no better way to market new food and drink products than to get people to try them, then PHLI has enormous upside. If it doesn't, with only $800K to start Q2 and a burn rate of about $100K per month, unless Forze sales kick in, the Company will have to do a raise. Another negative is that the Board needs strengthening. Biggest negative, and one common to many bb companies, is that if anything happens to the CEO that would be very bearish.
Stock Positives: low O/S; market cap around $5M; $7M in annual sales pre-ForzeGPS; $15M tax loss carry forward.
Stock Negatives: low trading volume, negative EPS
May 31 , 2009 • San Diego, CA
Home of the fastest marathon West of Chicago (2:08:33). Twenty-six stages host live music on the course while cheerleaders encourage runners to the finish, and the Running Elvi shake things up with their World-Record attempt. Join in the fun!
June 27, 2009 • Seattle, WA
A Running Nirvana...ideal running temperatures, beautiful scenery and an eclectic music scene are the perfect mix for the inaugural Rock 'n' Roll Seattle Marathon & 1/2 Marathon! Register today and treat yourself to a Pacific Northwest adventure.
August 2, 2009 • Chicago, IL
New Tour Date added to the Rock 'n' Roll Marathon Series! The rockin' mix of running and music re-energizes the legendary Chicago Distance Classic. You'll Get: A flat, fast course, live music while you run, an ultimate tour of Chicago and a rockin' good time!
September 6, 2009 • Virginia Beach, VA
With 20 live bands, 16 cheer squads, and thousands of spectators along the course, you'll see why Virginia Beach is the place to be Labor Day weekend. This race sells out every year. Register early!
September 20, 2009 • Philadelphia, PA
A True American Classic -- Since 1978. The ING Philadelphia Distance Run is the gold standard of half marathon. Enjoy a course that covers the historic and picturesque sections of Philly. Make it a family affair with the Philadelphia Children's Run for kids ages 3-12.
October 4, 2009 • San Jose, CA
The most convenient race you'll ever run! With the start, finish, expo and concert within 3 blocks of all major downtown hotels, and just 45 minutes from downtown San Francisco, the fun abounds!
October 18, 2009 • Downtown Denver, Colorado The Mile High Experience. Join us for the Denver Marathon - a premier marathon, half marathon and four-person ING Marathon Relay. This world-class event is Colorado's largest marathon and features a spectacular (and flat!) route highlighting all of Denver with incredible views of the mountains and the biggest post-race party in the Rockies!
November 15 , 2009 • San Antonio, TX
Heart, Soul, and Rock 'n' Roll! - Featuring ideal running temperatures, beautiful scenery, and non-stop entertainment, San Antonio proves to be the perfect destination for a late-fall running excursion. Combine your athletic conquests with a weekend getaway in Texas' #1 vacation destination.
December 6, 2009 • Las Vegas, NV
The REAL deal you've been waiting for - The ultimate Vegas running experience...without the risk. Featuring a high-energy, rockin' run, with action-packed courses, live entertainment every mile and flat, fast routes to help you beat the odds and run a P.R. Register to ROCK Vegas today!
The information in this iBox and all posts by the moderator should not be relied upon as complete, accurate or current. Do your own dd, and review the filings at the SEC. The moderator owns PHLI stock, and may buy or sell at any time, regardless of any information provided or opinions expressed.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |